Despite its checkered reputation, cryptocurrency is being considered by a handful of academics as a means to funnel funds into translational research. Is the trend likely to spread? Laura DeFrancesco and Ariel Klevecz investigate.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Ethics declarations
Competing interests
A.K. is a member of two DAOs, Myosin and Hifi.Labs.
Rights and permissions
About this article
Cite this article
DeFrancesco, L., Klevecz, A. Decentralized investor communities gain traction in biotech. Nat Biotechnol 40, 1310–1315 (2022). https://doi.org/10.1038/s41587-022-01459-z
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41587-022-01459-z
This article is cited by
-
The potential of DAOs for funding and collaborative development in the life sciences
Nature Biotechnology (2024)
-
The community of the DAO
Nature Biotechnology (2023)
